Trial intelligence / Profile preview

Effect of Roux-en-Y Gastric Bypass on Pharmacokinetics of Lansoprazole in Morbidly Obese Patients

TCTR20220118001Phase 4Recruiting

Sponsor
Chulalongkorn University Endowment Fund
Start
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lansoprazole in class III obesity, sponsored by Chulalongkorn University Endowment Fund. Started Nov 2021; status: recruiting.

02

Drugs

lansoprazole
03

Conditions

class III obesity

Beyond the preview

Go deeper on TCTR20220118001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20220118001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call